BNC Korea Co., Ltd. (KOSDAQ:256840)

South Korea · Delayed Price · Currency is KRW

4,630.00

-140.00 (-2.94%)

At close: Feb 6, 2026

Revenue by Product

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cosmetic (Fillers, Cosmetics, Botulinum Toxin, etc.)	51.97B
Cosmetic (Fillers, Cosmetics, Botulinum Toxin, etc.) Growth	30.89%
Pharmaceuticals and Medical Devices Diagnostic Reagents, etc.	23.07B
Pharmaceuticals and Medical Devices Diagnostic Reagents, etc. Growth	-24.37%
Surgical/Procedure Products (Wound Dressings, Tissue Replenishers, etc.)	11.28B
Surgical/Procedure Products (Wound Dressings, Tissue Replenishers, etc.) Growth	4.56%
Aesthetic Medical Devices (LA FILLE, CICU, SNOR STOP, etc.)	2.60B
Analysis and Experimental Services, etc.	274.91M
Medicines	29.99M

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Others Overseas	49.78B
Others Overseas Growth	32.98%
South Korea	36.14B
South Korea Growth	-13.04%
Russia	3.31B
Russia Growth	64.87%